BETA

IPO registrations (S-1, F-1) · Registrants

ARQULE INC

SEC CIK
1019695 · filings on EDGAR ↗
Registration
Form S-1, first filed 1996-08-29, last 1997-04-04; 2 initial registrations, 6 amendments
Outcome
No final prospectus, effectiveness notice or withdrawal within two years of the registration
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
ONE WALL STREET, FLOOR 6, Burlington, MA 01803
EIN
04-3221586
EDGAR entity type
operating
Insiders and CEO pay
ARQULE INC on the corporate pages

Offering terms

Shares offered
2,000,000
Listing
Nasdaq under the symbol ARQL
Lead underwriters
Hambrecht & Quist
Syndicate
Oppenheimer; Vector Securities International, Inc

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
1996-08-29S-1S-1 (registration)ARQULE INC0000950135-96-003873 ↗
1996-09-24S-1/AS-1/A (amendment)ARQULE INC0000950135-96-004060 ↗
1996-10-04S-1/AS-1/A (amendment)ARQULE INC0000950135-96-004275 ↗
1996-10-15S-1/AS-1/A (amendment)ARQULE INC0000950135-96-004355 ↗
1996-10-16S-1/AS-1/A (amendment)ARQULE INC0000950135-96-004382 ↗
1997-03-07S-1S-1 (registration)ARQULE INC0000950135-97-001120 ↗
1997-04-03S-1/AS-1/A (amendment)ARQULE INC0000950135-97-001651 ↗
1997-04-04S-1/AS-1/A (amendment)ARQULE INC0000950135-97-001667 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1997-04-04S-1/Aregistration statement$12.002,000,000$24,000,000Nasdaq ARQL3from the submission text; price sentence, shares headline, proceeds computed, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
HILL STEPHEN ADirector,Officer; OfficerPresident and CEO; President & CEO32006–2007
LI CHIANG JOfficerEVP, Chief Scientific Officer; VP, Chief Scientific Officer22006–2007
MAWHINNEY LOUISEOfficerVP and Chief Financial Officer12006
BARABE TIMOTHY CDirector1652006–2020
Lawrence Peter SOfficerChief Operating Office; Chief Operating Officer; Gen Counsel/Chief Business Off; President and COO; President & COO292006–2020
Simonian Nancy ADirector72006–2010
ASTRUE MICHAEL JDirector12006
HA NGOC TUANDirector12006
LINDSAY RONALD MDirector192006–2020
Messenger William GDirector172006–2020person page Fuzzy
ZENNER PATRICK JDirector262006–2020
RULEWSKI NIGEL JOfficerChief Medical Officer; Former Chief Medical Officer52006–2008
Woodrich Richard HOfficerActing Chief Financial Officer22006
LOBERG MICHAEL DDirector2102007–2020
Weiskopf Robert JOfficerChief Financial Officer; Vice President of Finance; VP Finance & Corp Controller242007–2019
BIOTECHNOLOGY VALUE FUND II LPOther; TenPercentOwnerOther262008–2018
BIOTECHNOLOGY VALUE FUND L POther; TenPercentOwner; TenPercentOwnerOther262008–2018
BVF INC/ILTenPercentOwner; TenPercentOwnerOther262008–2018
BVF INVESTMENTS LLCOther; TenPercentOwnerOther222008–2010
BVF PARTNERS L P/ILTenPercentOwner; TenPercentOwnerOther262008–2018
Pucci PaoloDirector,Officer; Officer; OtherChief Executive Officer472008–2020
SCHWARTZ BRIANOfficerChief Medical Officer; Chief Scientific Officer; See Remarks272008–2020
CHAN THOMAS C KOfficerChief Scientific Officer62008–2012
LAMPERT MARK NTenPercentOwner72009–2018
Kelley Susan L.Director132011–2020
Biotechnology Value Trading Fund OS LPOther42017–2018
BVF Partners OS Ltd.Other42017–2018
Nussbaum RanDirector122017–2020
SCHAMBER BLAINEOfficer; OtherVP Finance, CAO; VP, Finance, CAO52019–2020
SCHEGERIN MARCOfficerCFO and Treasurer; Chief Financial Officer; SVP and CFO42019–2020
Merck & Co., Inc.TenPercentOwner12019
Merck Sharp & Dohme Corp.TenPercentOwner12019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerARQULE INCSEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorARQULE, INC.EIN (EXACT)
Person pageWilliam G MessengerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health